EUVIMEDEUVIMED entdecken
Crossref

Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages

Elena Aiello, Giuseppina Emanuela Grieco, Michela Brunetti, Giulia Gliozzo, Daniela Fignani, Giuseppe Quero, Sergio Alfieri, Gianfranco Di Giuseppe, Gea Ciccarelli, Angela Dardano, Martina Parenti, Andrea Mari und 6 weitere

Diabetologia · 2026-09 · 69 (9) · 2620-2633

DOI: 10.1007/s00125-026-06766-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, online erschienen am 06.06.2026. Verfasst von Elena Aiello und 17 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Insulin-Secreting Cells, Diabetes Mellitus, Type 2, Glucose Intolerance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS/HYPOTHESIS: Type 2 diabetes mellitus is a multifactorial disease marked by progressive beta cell dysfunction; however, no reliable, easily measurable circulating biomarkers are currently available to track this decline. As microRNAs (miRNAs) tightly regulate beta cell physiology and are secreted and found in blood, we investigated whether specific circulating miRNAs reflect in vivo beta cell function in living donors. METHODS: We conducted a cross-sectional study on two independent cohorts: a discovery cohort comprising 78 individuals with different levels of glucose tolerance [23 with normal glucose tolerance (NGT), 22 with impaired glucose tolerance (IGT) and 33 with type 2 diabetes] and a validation cohort comprising 158 individuals (71 non-diabetic individuals and 87 with type 2 diabetes) who were administered an oral glucose tolerance test (OGTT) and/or a mixed meal test (MMT) with measurement of glucose, insulin and C-peptide. We profiled plasma RNA by small RNA sequencing, and analysed differences between glucose tolerance groups using DESeq2. We used linear regression analyses to determine the association between miRNA abundance and clinical and metabolic measures. We validated selected miRNAs using droplet digital PCR (ddPCR). Finally, we specified a set of features that were used as an input for a LASSO model to select a biomarker signature that was able to estimate beta cell rate sensitivity (RS) values as a measure of beta cell function. RESULTS: We identified 11 miRNAs that were differentially expressed across the three glucose tolerance groups of the discovery cohort. Integrated analyses pinpointed a three-miRNA signature (miR-34a-5p, miR-1306-5p and miR-335-5p) that correlated with beta cell RS, which is an early indicator of insulin secretory impairment. We incorporated this panel of selected miRNAs with age and 1 h post-load glucose into a LASSO regression model that enabled discrimination of RS values (Spearman's ρ=0.43, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsInsulin-Secreting CellsDiabetes Mellitus, Type 2Glucose IntoleranceHumansGlucose Tolerance TestFemaleMaleCross-Sectional StudiesMiddle AgedBlood GlucoseInsulinBiomarkersAdult

Stichwörter der Autor:innen

Beta cell functionBiomarkerMicroRNARate sensitivityType 2 diabetes

Substanzen

MicroRNAsBlood GlucoseInsulinBiomarkers

Autor:innen und Institutionen

  • Diabetes Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Fondazione Umberto Di Mario ONLUS c/o Toscana Life Science, Siena, Italy.
  • Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Endocrinology, Diabetes and Internal Medicine, Fondazione Policlinico Universitario Gemelli IRCCS, Roma, Italy.
  • Chirurgia Digestiva, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Förderung

  • Ministero dell'Università e della Ricerca
  • Ministero della Salute

Zitieren

APA

Aiello, E., Grieco, G. E., Brunetti, M., Gliozzo, G., Fignani, D., Quero, G., Alfieri, S., Di Giuseppe, G., Ciccarelli, G., Dardano, A., Parenti, M., Mari, A., Bizzotto, R., Daniele, G., Giaccari, A., Dotta, F., Sebastiani, G., & Mezza, T. (2026). Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages. Diabetologia, 69(9), 2620-2633. https://doi.org/10.1007/s00125-026-06766-7

Vancouver

Aiello E, Grieco GE, Brunetti M, Gliozzo G, Fignani D, Quero G, et al. Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages. Diabetologia. 2026;69(9):2620-2633. doi:10.1007/s00125-026-06766-7

BibTeX
@article{Aiello2026,
  author = {Aiello, Elena and Grieco, Giuseppina Emanuela and Brunetti, Michela and Gliozzo, Giulia and Fignani, Daniela and Quero, Giuseppe and Alfieri, Sergio and Di Giuseppe, Gianfranco and Ciccarelli, Gea and Dardano, Angela and Parenti, Martina and Mari, Andrea and Bizzotto, Roberto and Daniele, Giuseppe and Giaccari, Andrea and Dotta, Francesco and Sebastiani, Guido and Mezza, Teresa},
  title = {Plasma small RNA profiling reveals a three-miRNA signature associated with early beta cell dysfunction across glucose tolerance stages},
  journal = {Diabetologia},
  year = {2026},
  volume = {69},
  number = {9},
  pages = {2620--2633},
  doi = {10.1007/s00125-026-06766-7}
}
Kostenlos starten →